or Try an Advanced Search...

    Technical Analysis for CUE - Cue Biopharma, Inc.

    Grade Last Price % Change Price Change
    F 1.86 8.77% 0.15
    CUE closed down 1.72 percent on Friday, May 17, 2024, on 40 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: Jun 5
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical CUE trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 8.77%
    NR7 Range Contraction 8.77%
    Inside Day Range Contraction 8.77%
    Wide Bands Range Expansion 8.77%
    50 DMA Resistance Bearish 6.90%
    Bullish Engulfing Bullish 6.90%
    Crossed Above 20 DMA Bullish 6.90%
    Wide Bands Range Expansion 6.90%
    Hammer Candlestick Bullish 13.41%
    Lizard Bullish Bullish Day Trade Setup 13.41%
    Older End-of-Day Signals for CUE ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 1 hour ago
    Rose Above Previous Day's High about 1 hour ago
    Rose Above 50 DMA about 1 hour ago
    Rose Above 10 DMA about 1 hour ago
    Up 5% about 1 hour ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CUE Chart by TradingView
    Basic chart:

    Profile

    Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Immune System Pharmacy Medication Autoimmunity Specialty Drugs Autoimmune Disorders Immune Disorders

    Is CUE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 11 Cue Biopharma First Quarter 2024 Earnings: Beats Expectations
    May 9 Cue Biopharma GAAP EPS of -$0.25 beats by $0.03, revenue of $1.7M beats by $0.49M
    May 9 Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
    May 8 Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
    Apr 24 Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    Apr 9 Q4 2023 Cue Biopharma Inc Earnings Call
    Apr 9 Cue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ...
    Apr 9 Cue Biopharma, Inc. (CUE) Q4 2023 Earnings Call Transcript
    Apr 8 Cue Biopharma GAAP EPS of -$0.28 misses by $0.01
    Apr 8 Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
    See more CUE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.89
    52 Week Low 1.3027
    Average Volume 296,968
    200-Day Moving Average 2.35
    50-Day Moving Average 1.80
    20-Day Moving Average 1.73
    10-Day Moving Average 1.81
    Average True Range 0.20
    RSI (14) 47.64
    ADX 19.24
    +DI 21.82
    -DI 20.25
    Chandelier Exit (Long, 3 ATRs) 1.66
    Chandelier Exit (Short, 3 ATRs) 1.90
    Upper Bollinger Bands 2.22
    Lower Bollinger Band 1.24
    Percent B (%b) 0.48
    BandWidth 56.31
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0118
    Fundamentals Value
    Market Cap 77.16 Million
    Num Shares 45.1 Million
    EPS -1.20
    Price-to-Earnings (P/E) Ratio -1.43
    Price-to-Sales 27.76
    Price-to-Book 2.46
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.88
    Resistance 3 (R3) 1.88 1.82 1.85
    Resistance 2 (R2) 1.82 1.78 1.82 1.84
    Resistance 1 (R1) 1.77 1.76 1.74 1.77 1.83
    Pivot Point 1.71 1.71 1.70 1.71 1.71
    Support 1 (S1) 1.66 1.67 1.63 1.66 1.59
    Support 2 (S2) 1.60 1.65 1.60 1.58
    Support 3 (S3) 1.55 1.60 1.57
    Support 4 (S4) 1.55